Selected research
Industry Research
Life Sciences Transactions Service Industry Research Report 2026
Market perspective
The global Life Sciences Transactions Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Life Sciences Transactions Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Life Sciences Transactions Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Life Sciences Transactions Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Life Sciences Transactions Service include A&L Goodbody, Arnold & Porter, Baker McKenzie, Covington, DLA Piper, HaysMac, Holland & Knight, Kirkland & Ellis LLP and L.E.K. Consulting, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Life Sciences Transactions Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Life Sciences Transactions Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Life Sciences Transactions Service Market by Company
A&L Goodbody
Arnold & Porter
Baker McKenzie
Covington
DLA Piper
HaysMac
Holland & Knight
Kirkland & Ellis LLP
L.E.K. Consulting
Morgan Lewis
Osborne Clarke
Pharma Bio Source
Pinnacle
Reed Smith LLP
RNA Advisors
Sidley Austin
Tenthpin
Troutman Pepper Locke
WilmerHale
Life Sciences Transactions Service Segment by Type
Intellectual Property Licensing Transactions
Product Asset Transactions
Equity Mergers and Acquisitions
Other
Life Sciences Transactions Service Segment by Application
Biopharmaceuticals and Innovative Therapies
Medical Devices and Diagnostics
Contract Research, Development, and Manufacturing Organizations
Digital Health and Healthcare Services
Others
Life Sciences Transactions Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life Sciences Transactions Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Life Sciences Transactions Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life Sciences Transactions Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Life Sciences Transactions Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intellectual Property Licensing Transactions
- Product Asset Transactions
- Equity Mergers and Acquisitions
- Other
Applications
- Biopharmaceuticals and Innovative Therapies
- Medical Devices and Diagnostics
- Contract Research, Development, and Manufacturing Organizations
- Digital Health and Healthcare Services
- Others
Companies covered
- A&L Goodbody
- Arnold & Porter
- Baker McKenzie
- Covington
- DLA Piper
- HaysMac
- Holland & Knight
- Kirkland & Ellis LLP
- L.E.K. Consulting
- Morgan Lewis
- Osborne Clarke
- Pharma Bio Source
- Pinnacle
- Reed Smith LLP
- RNA Advisors
- Sidley Austin
- Tenthpin
- Troutman Pepper Locke
- WilmerHale
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Life Sciences Transactions Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Intellectual Property Licensing Transactions
- 2.2.3 Product Asset Transactions
- 2.2.4 Equity Mergers and Acquisitions
- 2.2.5 Other
- 2.3 Life Sciences Transactions Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceuticals and Innovative Therapies
- 2.3.3 Medical Devices and Diagnostics
- 2.3.4 Contract Research, Development, and Manufacturing Organizations
- 2.3.5 Digital Health and Healthcare Services
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Life Sciences Transactions Service Breakdown Data by Type
- 3.1 Global Life Sciences Transactions Service Historic Market Size by Type (2021-2026)
- 3.2 Global Life Sciences Transactions Service Forecasted Market Size by Type (2027-2032)
4 Life Sciences Transactions Service Breakdown Data by Application
- 4.1 Global Life Sciences Transactions Service Historic Market Size by Application (2021-2026)
- 4.2 Global Life Sciences Transactions Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Life Sciences Transactions Service Market Perspective (2021-2032)
- 5.2 Global Life Sciences Transactions Service Growth Trends by Region
- 5.2.1 Global Life Sciences Transactions Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Life Sciences Transactions Service Historic Market Size by Region (2021-2026)
- 5.2.3 Life Sciences Transactions Service Forecasted Market Size by Region (2027-2032)
- 5.3 Life Sciences Transactions Service Market Dynamics
- 5.3.1 Life Sciences Transactions Service Industry Trends
- 5.3.2 Life Sciences Transactions Service Market Drivers
- 5.3.3 Life Sciences Transactions Service Market Challenges
- 5.3.4 Life Sciences Transactions Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Life Sciences Transactions Service Players by Revenue
- 6.1.1 Global Top Life Sciences Transactions Service Players by Revenue (2021-2026)
- 6.1.2 Global Life Sciences Transactions Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Life Sciences Transactions Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Life Sciences Transactions Service Head Office and Area Served
- 6.4 Global Life Sciences Transactions Service Players, Product Type & Application
- 6.5 Global Life Sciences Transactions Service Manufacturers Established Date
- 6.6 Global Life Sciences Transactions Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Life Sciences Transactions Service Market Size (2021-2032)
- 7.2 North America Life Sciences Transactions Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Life Sciences Transactions Service Market Size by Country (2021-2026)
- 7.4 North America Life Sciences Transactions Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Life Sciences Transactions Service Market Size (2021-2032)
- 8.2 Europe Life Sciences Transactions Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Life Sciences Transactions Service Market Size by Country (2021-2026)
- 8.4 Europe Life Sciences Transactions Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Life Sciences Transactions Service Market Size (2021-2032)
- 9.2 Asia-Pacific Life Sciences Transactions Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Life Sciences Transactions Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Life Sciences Transactions Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Life Sciences Transactions Service Market Size (2021-2032)
- 10.2 South America Life Sciences Transactions Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Life Sciences Transactions Service Market Size by Country (2021-2026)
- 10.4 South America Life Sciences Transactions Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Life Sciences Transactions Service Market Size (2021-2032)
- 11.2 Middle East & Africa Life Sciences Transactions Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Life Sciences Transactions Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Life Sciences Transactions Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 A&L Goodbody
- 12.1.1 A&L Goodbody Company Information
- 12.1.2 A&L Goodbody Business Overview
- 12.1.3 A&L Goodbody Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.1.4 A&L Goodbody Life Sciences Transactions Service Product Portfolio
- 12.1.5 A&L Goodbody Recent Developments
- 12.2 Arnold & Porter
- 12.2.1 Arnold & Porter Company Information
- 12.2.2 Arnold & Porter Business Overview
- 12.2.3 Arnold & Porter Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.2.4 Arnold & Porter Life Sciences Transactions Service Product Portfolio
- 12.2.5 Arnold & Porter Recent Developments
- 12.3 Baker McKenzie
- 12.3.1 Baker McKenzie Company Information
- 12.3.2 Baker McKenzie Business Overview
- 12.3.3 Baker McKenzie Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.3.4 Baker McKenzie Life Sciences Transactions Service Product Portfolio
- 12.3.5 Baker McKenzie Recent Developments
- 12.4 Covington
- 12.4.1 Covington Company Information
- 12.4.2 Covington Business Overview
- 12.4.3 Covington Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.4.4 Covington Life Sciences Transactions Service Product Portfolio
- 12.4.5 Covington Recent Developments
- 12.5 DLA Piper
- 12.5.1 DLA Piper Company Information
- 12.5.2 DLA Piper Business Overview
- 12.5.3 DLA Piper Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.5.4 DLA Piper Life Sciences Transactions Service Product Portfolio
- 12.5.5 DLA Piper Recent Developments
- 12.6 HaysMac
- 12.6.1 HaysMac Company Information
- 12.6.2 HaysMac Business Overview
- 12.6.3 HaysMac Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.6.4 HaysMac Life Sciences Transactions Service Product Portfolio
- 12.6.5 HaysMac Recent Developments
- 12.7 Holland & Knight
- 12.7.1 Holland & Knight Company Information
- 12.7.2 Holland & Knight Business Overview
- 12.7.3 Holland & Knight Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.7.4 Holland & Knight Life Sciences Transactions Service Product Portfolio
- 12.7.5 Holland & Knight Recent Developments
- 12.8 Kirkland & Ellis LLP
- 12.8.1 Kirkland & Ellis LLP Company Information
- 12.8.2 Kirkland & Ellis LLP Business Overview
- 12.8.3 Kirkland & Ellis LLP Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.8.4 Kirkland & Ellis LLP Life Sciences Transactions Service Product Portfolio
- 12.8.5 Kirkland & Ellis LLP Recent Developments
- 12.9 L.E.K. Consulting
- 12.9.1 L.E.K. Consulting Company Information
- 12.9.2 L.E.K. Consulting Business Overview
- 12.9.3 L.E.K. Consulting Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.9.4 L.E.K. Consulting Life Sciences Transactions Service Product Portfolio
- 12.9.5 L.E.K. Consulting Recent Developments
- 12.10 Morgan Lewis
- 12.10.1 Morgan Lewis Company Information
- 12.10.2 Morgan Lewis Business Overview
- 12.10.3 Morgan Lewis Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.10.4 Morgan Lewis Life Sciences Transactions Service Product Portfolio
- 12.10.5 Morgan Lewis Recent Developments
- 12.11 Osborne Clarke
- 12.11.1 Osborne Clarke Company Information
- 12.11.2 Osborne Clarke Business Overview
- 12.11.3 Osborne Clarke Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.11.4 Osborne Clarke Life Sciences Transactions Service Product Portfolio
- 12.11.5 Osborne Clarke Recent Developments
- 12.12 Pharma Bio Source
- 12.12.1 Pharma Bio Source Company Information
- 12.12.2 Pharma Bio Source Business Overview
- 12.12.3 Pharma Bio Source Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.12.4 Pharma Bio Source Life Sciences Transactions Service Product Portfolio
- 12.12.5 Pharma Bio Source Recent Developments
- 12.13 Pinnacle
- 12.13.1 Pinnacle Company Information
- 12.13.2 Pinnacle Business Overview
- 12.13.3 Pinnacle Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.13.4 Pinnacle Life Sciences Transactions Service Product Portfolio
- 12.13.5 Pinnacle Recent Developments
- 12.14 Reed Smith LLP
- 12.14.1 Reed Smith LLP Company Information
- 12.14.2 Reed Smith LLP Business Overview
- 12.14.3 Reed Smith LLP Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.14.4 Reed Smith LLP Life Sciences Transactions Service Product Portfolio
- 12.14.5 Reed Smith LLP Recent Developments
- 12.15 RNA Advisors
- 12.15.1 RNA Advisors Company Information
- 12.15.2 RNA Advisors Business Overview
- 12.15.3 RNA Advisors Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.15.4 RNA Advisors Life Sciences Transactions Service Product Portfolio
- 12.15.5 RNA Advisors Recent Developments
- 12.16 Sidley Austin
- 12.16.1 Sidley Austin Company Information
- 12.16.2 Sidley Austin Business Overview
- 12.16.3 Sidley Austin Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.16.4 Sidley Austin Life Sciences Transactions Service Product Portfolio
- 12.16.5 Sidley Austin Recent Developments
- 12.17 Tenthpin
- 12.17.1 Tenthpin Company Information
- 12.17.2 Tenthpin Business Overview
- 12.17.3 Tenthpin Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.17.4 Tenthpin Life Sciences Transactions Service Product Portfolio
- 12.17.5 Tenthpin Recent Developments
- 12.18 Troutman Pepper Locke
- 12.18.1 Troutman Pepper Locke Company Information
- 12.18.2 Troutman Pepper Locke Business Overview
- 12.18.3 Troutman Pepper Locke Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.18.4 Troutman Pepper Locke Life Sciences Transactions Service Product Portfolio
- 12.18.5 Troutman Pepper Locke Recent Developments
- 12.19 WilmerHale
- 12.19.1 WilmerHale Company Information
- 12.19.2 WilmerHale Business Overview
- 12.19.3 WilmerHale Revenue in Life Sciences Transactions Service Business (2021-2026)
- 12.19.4 WilmerHale Life Sciences Transactions Service Product Portfolio
- 12.19.5 WilmerHale Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst